Therapy-induced clearance of HCV core antigen from plasma predicts an end of treatment viral response. (Q42987172)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23231086%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Therapy-induced clearance of HCV core antigen from plasma predicts an end of treatment viral response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23231086%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23231086%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

P Tuke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23231086%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

N Wallis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23231086%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

M Wright

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23231086%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

L Nicholson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23231086%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

P R Grant

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23231086%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

4 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23231086%20AND%20SRC:MED&resulttype=core&format=json

Journal of Viral Hepatitis

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23231086%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23231086%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23231086%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

65-71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23231086%20AND%20SRC:MED&resulttype=core&format=json

Demonstration of a hepatitis C virus-specific antigen predicted from the putative core gene in the circulation of infected hosts

20 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01630.X

Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01630.X

Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01630.X

Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01630.X

Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01630.X

A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01630.X

Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: a multicentre randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01630.X

Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C--clinical and virologic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01630.X

Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01630.X

Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01630.X

Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01630.X

Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01630.X

Hepatitis C virus (HCV) core antigen detection in HCV RNA-positive/anti-HCV-negative Polish blood donors identified by nucleic acid testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01630.X

Profiles of HCV core protein and viremia in chronic hepatitis C: possible protective role of core antigen in liver damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01630.X

Analytical Performance Characteristics and Clinical Utility of a Novel Assay for Total Hepatitis C Virus Core Antigen Quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01630.X